The physical and mental health consequences of chronic illness are among the most difficult to handle problems encountered by therapists and psychologists in children and adolescents. This volume in the new series, Advances in Psychotherapy -- Evidence-Based Practice, provides therapists and students with practical and evidence-based guidance on diagnosis and treatment of chronic illnesses and their consequences, and does so in a uniquely "reader-friendly" manner. The book is both a compact "how-to" reference, for use by professional clinicians in their daily work, as well as an ideal educational resource for students and for practice-oriented continuing education.The most important feature of the book is that it is practical and "reader-friendly." It has a similar structure to others in the series, and is a compact and easy-to-follow guide covering all aspects of practice that are relevant in real-life. Tables, boxed clinical "pearls," and marginal notes assist orientation, while checklists for copying and summary boxes provide tools for use in daily practice.The series has been developed and is edited with the support of the Society of Clinical Psychology (APA Division 12). The Society is planning a system of home study continuing education courses based on the series that an individual can complete on the web.
Texte du rabat
Management of chronic illness in children and adolescents often is a multifaceted challenge that requires the attention and expertise of individuals from a variety of disciplines that include psychology, psychiatry, social work, and medicine. The aim of this book is to provide readers with a practical overview of the definitions, characteristics, theories and models, diagnostic and treatment indications, and relevant aspects and methods of evidence-based psychosocial treatments for chronic illness in children and adolescents. Although treatments and research for chronic conditions are reviewed in general, particular attention is directed at asthma, cancer, cystic fibrosis, diabetes mellitus, and sickle cell disease due to the high incidence of these chronic diseases among children and adolescents. Case vignettes and suggestions for further reading are provided for the interested reader.
Contenu
Acknowledgments; 1 Description; 1.1 Terminology; 1.2 Definition; 1.3 Epidemiology: Incidence and Prevalence; 1.4 Course and Prognosis: Asthma Cancer Cystic Fibrosis Diabetes Mellitus Sickle Cell Disease; 1.5 Differential Diagnosis; 1.6 Comorbidities: Asthma Cancer Cystic Fibrosis Diabetes Mellitus Sickle Cell Disease; 1.7 Diagnostic Procedures and Documentation; 2 Theories and Models of the Disorder; 2.1 Risk Factors: Disease and Disability Parameters Genetic Disorders Intrauterine Growth Retardation, Prematurity, and Low Birth Weight Teratogens Disease Severity Functional Independence Psychosocial Stressors; 2.2 Resistance Factors: Intrapersonal Factors; 2.3 Social-Ecological Factors: Family Functioning Financial Resources Stress Processing; 2.4 Applying the Models to Sickle Cell Disease; 3 Diagnosis and Treatment Indications; 3.1 Caregiver and Child Interviews; 3.2 Behavior; 3.3 Cognition; 3.4 Affect; 3.5 Adherence; 3.6 Stress and Coping; 3.7 Quality of Life; 3.8 Family Variables; 3.9 Summary; 4 Treatment; 4.1 Methods of Treatment: Behavior Therapy Cognitive-Behavior Therapy Behavioral and Cognitive-Behavioral Interventions - Empirical Support and Clinical Trials Psychological Adjustment Psychosocial Factors, Coping, and Pain Management Adherence Family Systems Interventions Parent Training Group Therapy Peer Group Interventions Peer Support Groups Electronic Peer Support Groups Self-Regulatory Skill Training, Self-Management, and Psychoeducational Strategies; 4.2 Mechanisms of Action; 4.3 Efficacy and Prognosis; 4.4 Variations and Combinations of Methods; 4.5 Problems in Carrying out the Treatment: Individual Barriers Family Barriers Provider Barriers * System and Setting-Based Barriers; 4.6 Multicultural Issues; 4.7 Summary; 5 Case Vignette; 6 Further Reading; 7 References; 8 Appendix: Tools and Resources.